APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemoperfusion

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.

Selected research

Market Analysis & Forecast

Global Hemoperfusion Market Analysis and Forecast 2026-2032

20 December 2025198 pages

Choose your research edition.

Industry ResearchHemoperfusion Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemoperfusion Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Hemoperfusion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemoperfusion Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemoperfusion Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.

China is the largest Hemoperfusion market with about 65% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei etc. Top 3 companies occupied about 81% market share.

This report presents an overview of global market for Hemoperfusion, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Hemoperfusion, also provides the sales of main regions and countries. Of the upcoming market potential for Hemoperfusion, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hemoperfusion sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hemoperfusion market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hemoperfusion sales, projected growth trends, production technology, application and end-user industry.

Hemoperfusion Segment by Company

Jafron Biomedical

Baxter (Gambro)

Asahi-Kasei

Biosun Medical

Kaneka

Toray Medical

Cytosorbents

Aier

Zibo Kangbei

Hemoperfusion Segment by Type

Activated Carbon Adsorption

Resin Adsorption

Hemoperfusion Segment by Application

Hepatic Encephalopathy

Certain Autoimmune Diseases

Drug Overdose

Specific Intoxications

Others

Hemoperfusion Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemoperfusion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemoperfusion and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemoperfusion.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hemoperfusion in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hemoperfusion manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemoperfusion sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hemoperfusion Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Activated Carbon Adsorption Major Manufacturers Table 3. Resin Adsorption Major Manufacturers Table 4. Global Hemoperfusion Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hepatic Encephalopathy Major Manufacturers Table 6. Certain Autoimmune Diseases Major Manufacturers Table 7. Drug Overdose Major Manufacturers Table 8. Specific Intoxications Major Manufacturers Table 9. Others Major Manufacturers Table 10. Hemoperfusion Industry Trends Table 11. Hemoperfusion Industry Drivers Table 12. Hemoperfusion Industry Opportunities and Challenges Table 13. Hemoperfusion Industry Restraints Table 14. Global Hemoperfusion Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Hemoperfusion Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Hemoperfusion Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Hemoperfusion Revenue Market Share by Region (2021-2026) Table 18. Global Hemoperfusion Revenue Market Share by Region (2027-2032) Table 19. Global Hemoperfusion Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Hemoperfusion Sales by Region (2021-2026) & (K Units) Table 21. Global Hemoperfusion Sales by Region (2027-2032) & (K Units) Table 22. Global Hemoperfusion Sales Market Share by Region (2021-2026) Table 23. Global Hemoperfusion Sales Market Share by Region (2027-2032) Table 24. Global Hemoperfusion Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Hemoperfusion Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Hemoperfusion Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Hemoperfusion Sales Market Share by Manufacturers (2021-2026) Table 28. Global Hemoperfusion Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 29. Global Hemoperfusion Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Hemoperfusion Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Hemoperfusion Manufacturers, Product Type & Application Table 32. Global Hemoperfusion Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Hemoperfusion by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Hemoperfusion Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Hemoperfusion Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Hemoperfusion Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Hemoperfusion Revenue Market Share by Type (2021-2026) Table 39. Global Hemoperfusion Revenue Market Share by Type (2027-2032) Table 40. Global Hemoperfusion Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Hemoperfusion Sales by Type (2021-2026) & (K Units) Table 42. Global Hemoperfusion Sales by Type (2027-2032) & (K Units) Table 43. Global Hemoperfusion Sales Market Share by Type (2021-2026) Table 44. Global Hemoperfusion Sales Market Share by Type (2027-2032) Table 45. Global Hemoperfusion Price by Type (2021-2026) & (USD/Unit) Table 46. Global Hemoperfusion Price by Type (2027-2032) & (USD/Unit) Table 47. Global Hemoperfusion Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Hemoperfusion Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Hemoperfusion Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Hemoperfusion Revenue Market Share by Application (2021-2026) Table 51. Global Hemoperfusion Revenue Market Share by Application (2027-2032) Table 52. Global Hemoperfusion Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Hemoperfusion Sales by Application (2021-2026) & (K Units) Table 54. Global Hemoperfusion Sales by Application (2027-2032) & (K Units) Table 55. Global Hemoperfusion Sales Market Share by Application (2021-2026) Table 56. Global Hemoperfusion Sales Market Share by Application (2027-2032) Table 57. Global Hemoperfusion Price by Application (2021-2026) & (USD/Unit) Table 58. Global Hemoperfusion Price by Application (2027-2032) & (USD/Unit) Table 59. Jafron Biomedical Company Information Table 60. Jafron Biomedical Business Overview Table 61. Jafron Biomedical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 62. Jafron Biomedical Hemoperfusion Product Portfolio Table 63. Jafron Biomedical Recent Development Table 64. Baxter (Gambro) Company Information Table 65. Baxter (Gambro) Business Overview Table 66. Baxter (Gambro) Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. Baxter (Gambro) Hemoperfusion Product Portfolio Table 68. Baxter (Gambro) Recent Development Table 69. Asahi-Kasei Company Information Table 70. Asahi-Kasei Business Overview Table 71. Asahi-Kasei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. Asahi-Kasei Hemoperfusion Product Portfolio Table 73. Asahi-Kasei Recent Development Table 74. Biosun Medical Company Information Table 75. Biosun Medical Business Overview Table 76. Biosun Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Biosun Medical Hemoperfusion Product Portfolio Table 78. Biosun Medical Recent Development Table 79. Kaneka Company Information Table 80. Kaneka Business Overview Table 81. Kaneka Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Kaneka Hemoperfusion Product Portfolio Table 83. Kaneka Recent Development Table 84. Toray Medical Company Information Table 85. Toray Medical Business Overview Table 86. Toray Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Toray Medical Hemoperfusion Product Portfolio Table 88. Toray Medical Recent Development Table 89. Cytosorbents Company Information Table 90. Cytosorbents Business Overview Table 91. Cytosorbents Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Cytosorbents Hemoperfusion Product Portfolio Table 93. Cytosorbents Recent Development Table 94. Aier Company Information Table 95. Aier Business Overview Table 96. Aier Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Aier Hemoperfusion Product Portfolio Table 98. Aier Recent Development Table 99. Zibo Kangbei Company Information Table 100. Zibo Kangbei Business Overview Table 101. Zibo Kangbei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Zibo Kangbei Hemoperfusion Product Portfolio Table 103. Zibo Kangbei Recent Development Table 104. North America Hemoperfusion Revenue by Type (2021-2026) & (US$ Million) Table 105. North America Hemoperfusion Revenue by Type (2027-2032) & (US$ Million) Table 106. North America Hemoperfusion Sales by Type (2021-2026) & (K Units) Table 107. North America Hemoperfusion Sales by Type (2027-2032) & (K Units) Table 108. North America Hemoperfusion Sales Price by Type (2021-2026) & (USD/Unit) Table 109. North America Hemoperfusion Sales Price by Type (2027-2032) & (USD/Unit) Table 110. North America Hemoperfusion Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Hemoperfusion Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Hemoperfusion Sales by Application (2021-2026) & (K Units) Table 113. North America Hemoperfusion Sales by Application (2027-2032) & (K Units) Table 114. North America Hemoperfusion Sales Price by Application (2021-2026) & (USD/Unit) Table 115. North America Hemoperfusion Sales Price by Application (2027-2032) & (USD/Unit) Table 116. North America Hemoperfusion Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Hemoperfusion Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. North America Hemoperfusion Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. North America Hemoperfusion Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 120. North America Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 121. North America Hemoperfusion Sales by Country (2027-2032) & (K Units) Table 122. North America Hemoperfusion Sales Price by Country (2021-2026) & (USD/Unit) Table 123. North America Hemoperfusion Sales Price by Country (2027-2032) & (USD/Unit) Table 124. United States Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 125. Canada Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 126. Mexico Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 127. Europe Hemoperfusion Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Hemoperfusion Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Hemoperfusion Sales by Type (2021-2026) & (K Units) Table 130. Europe Hemoperfusion Sales by Type (2027-2032) & (K Units) Table 131. Europe Hemoperfusion Sales Price by Type (2021-2026) & (USD/Unit) Table 132. Europe Hemoperfusion Sales Price by Type (2027-2032) & (USD/Unit) Table 133. Europe Hemoperfusion Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Hemoperfusion Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Hemoperfusion Sales by Application (2021-2026) & (K Units) Table 136. Europe Hemoperfusion Sales by Application (2027-2032) & (K Units) Table 137. Europe Hemoperfusion Sales Price by Application (2021-2026) & (USD/Unit) Table 138. Europe Hemoperfusion Sales Price by Application (2027-2032) & (USD/Unit) Table 139. Europe Hemoperfusion Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Hemoperfusion Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Europe Hemoperfusion Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Europe Hemoperfusion Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 143. Europe Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 144. Europe Hemoperfusion Sales by Country (2027-2032) & (K Units) Table 145. Europe Hemoperfusion Sales Price by Country (2021-2026) & (USD/Unit) Table 146. Europe Hemoperfusion Sales Price by Country (2027-2032) & (USD/Unit) Table 147. Germany Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 148. France Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 149. U.K. Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 150. Italy Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 151. Russia Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 152. Spain Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 153. Netherlands Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 154. Switzerland Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 155. Sweden Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 156. Poland Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 157. China Hemoperfusion Revenue by Type (2021-2026) & (US$ Million) Table 158. China Hemoperfusion Revenue by Type (2027-2032) & (US$ Million) Table 159. China Hemoperfusion Sales by Type (2021-2026) & (K Units) Table 160. China Hemoperfusion Sales by Type (2027-2032) & (K Units) Table 161. China Hemoperfusion Sales Price by Type (2021-2026) & (USD/Unit) Table 162. China Hemoperfusion Sales Price by Type (2027-2032) & (USD/Unit) Table 163. China Hemoperfusion Revenue by Application (2021-2026) & (US$ Million) Table 164. China Hemoperfusion Revenue by Application (2027-2032) & (US$ Million) Table 165. China Hemoperfusion Sales by Application (2021-2026) & (K Units) Table 166. China Hemoperfusion Sales by Application (2027-2032) & (K Units) Table 167. China Hemoperfusion Sales Price by Application (2021-2026) & (USD/Unit) Table 168. China Hemoperfusion Sales Price by Application (2027-2032) & (USD/Unit) Table 169. Asia Hemoperfusion Revenue by Type (2021-2026) & (US$ Million) Table 170. Asia Hemoperfusion Revenue by Type (2027-2032) & (US$ Million) Table 171. Asia Hemoperfusion Sales by Type (2021-2026) & (K Units) Table 172. Asia Hemoperfusion Sales by Type (2027-2032) & (K Units) Table 173. Asia Hemoperfusion Sales Price by Type (2021-2026) & (USD/Unit) Table 174. Asia Hemoperfusion Sales Price by Type (2027-2032) & (USD/Unit) Table 175. Asia Hemoperfusion Revenue by Application (2021-2026) & (US$ Million) Table 176. Asia Hemoperfusion Revenue by Application (2027-2032) & (US$ Million) Table 177. Asia Hemoperfusion Sales by Application (2021-2026) & (K Units) Table 178. Asia Hemoperfusion Sales by Application (2027-2032) & (K Units) Table 179. Asia Hemoperfusion Sales Price by Application (2021-2026) & (USD/Unit) Table 180. Asia Hemoperfusion Sales Price by Application (2027-2032) & (USD/Unit) Table 181. Asia Hemoperfusion Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. Asia Hemoperfusion Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. Asia Hemoperfusion Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. Asia Hemoperfusion Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 185. Asia Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 186. Asia Hemoperfusion Sales by Country (2027-2032) & (K Units) Table 187. Asia Hemoperfusion Sales Price by Country (2021-2026) & (USD/Unit) Table 188. Asia Hemoperfusion Sales Price by Country (2027-2032) & (USD/Unit) Table 189. Japan Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 190. South Korea Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 191. India Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 192. Australia Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 193. Taiwan Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 194. Southeast Asia Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 195. SAMEA Hemoperfusion Revenue by Type (2021-2026) & (US$ Million) Table 196. SAMEA Hemoperfusion Revenue by Type (2027-2032) & (US$ Million) Table 197. SAMEA Hemoperfusion Sales by Type (2021-2026) & (K Units) Table 198. SAMEA Hemoperfusion Sales by Type (2027-2032) & (K Units) Table 199. SAMEA Hemoperfusion Sales Price by Type (2021-2026) & (USD/Unit) Table 200. SAMEA Hemoperfusion Sales Price by Type (2027-2032) & (USD/Unit) Table 201. SAMEA Hemoperfusion Revenue by Application (2021-2026) & (US$ Million) Table 202. SAMEA Hemoperfusion Revenue by Application (2027-2032) & (US$ Million) Table 203. SAMEA Hemoperfusion Sales by Application (2021-2026) & (K Units) Table 204. SAMEA Hemoperfusion Sales by Application (2027-2032) & (K Units) Table 205. SAMEA Hemoperfusion Sales Price by Application (2021-2026) & (USD/Unit) Table 206. SAMEA Hemoperfusion Sales Price by Application (2027-2032) & (USD/Unit) Table 207. SAMEA Hemoperfusion Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. SAMEA Hemoperfusion Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. SAMEA Hemoperfusion Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. SAMEA Hemoperfusion Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 211. SAMEA Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 212. SAMEA Hemoperfusion Sales by Country (2027-2032) & (K Units) Table 213. SAMEA Hemoperfusion Sales Price by Country (2021-2026) & (USD/Unit) Table 214. SAMEA Hemoperfusion Sales Price by Country (2027-2032) & (USD/Unit) Table 215. Brazil Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 216. Argentina Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 217. Chile Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 218. Colombia Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 219. Peru Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 220. Saudi Arabia Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 221. Israel Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 222. UAE Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 223. Turkey Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 224. Iran Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 225. Egypt Hemoperfusion Revenue (2021-2032) & (US$ Million) Table 226. Key Raw Materials Table 227. Raw Materials Key Suppliers Table 228. Hemoperfusion Distributors List Table 229. Hemoperfusion Customers List Table 230. Research Programs/Design for This Report Table 231. Authors List of This Report Table 232. Secondary Sources Table 233. Primary Sources List of Figures Figure 1. Hemoperfusion Image Figure 2. Global Hemoperfusion Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemoperfusion Market Size Share 2021 VS 2025 VS 2032 Figure 4. Activated Carbon Adsorption Image Figure 5. Resin Adsorption Image Figure 6. Global Hemoperfusion Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Hemoperfusion Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hepatic Encephalopathy Image Figure 9. Certain Autoimmune Diseases Image Figure 10. Drug Overdose Image Figure 11. Specific Intoxications Image Figure 12. Others Image Figure 13. Global Hemoperfusion Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Hemoperfusion Revenue (2021-2032) & (US$ Million) Figure 15. Global Hemoperfusion Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Hemoperfusion Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Hemoperfusion Revenue Market Share by Region (2021-2032) Figure 18. Global Hemoperfusion Sales (2021-2032) & (K Units) Figure 19. Global Hemoperfusion Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Hemoperfusion Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Hemoperfusion Sales YoY (2021-2032) & (K Units) Figure 22. Europe Hemoperfusion Sales YoY (2021-2032) & (K Units) Figure 23. China Hemoperfusion Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Hemoperfusion Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Hemoperfusion Sales YoY (2021-2032) & (K Units) Figure 26. Global Hemoperfusion Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Hemoperfusion Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Hemoperfusion Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Hemoperfusion Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Hemoperfusion Revenue Market Share by Type (2021-2032) Figure 32. Global Hemoperfusion Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Hemoperfusion Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Hemoperfusion Sales Market Share by Type (2021-2032) Figure 35. Global Hemoperfusion Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Hemoperfusion Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Hemoperfusion Revenue Market Share by Application (2021-2032) Figure 38. Global Hemoperfusion Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Hemoperfusion Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Hemoperfusion Sales Market Share by Application (2021-2032) Figure 41. North America Hemoperfusion Revenue Share by Type (2021-2032) Figure 42. North America Hemoperfusion Sales Share by Type (2021-2032) Figure 43. North America Hemoperfusion Revenue Share by Application (2021-2032) Figure 44. North America Hemoperfusion Sales Share by Application (2021-2032) Figure 45. North America Hemoperfusion Revenue Share by Country (2021-2032) Figure 46. North America Hemoperfusion Sales Share by Country (2021-2032) Figure 47. Europe Hemoperfusion Revenue Share by Type (2021-2032) Figure 48. Europe Hemoperfusion Sales Share by Type (2021-2032) Figure 49. Europe Hemoperfusion Revenue Share by Application (2021-2032) Figure 50. Europe Hemoperfusion Sales Share by Application (2021-2032) Figure 51. Europe Hemoperfusion Revenue Share by Country (2021-2032) Figure 52. Europe Hemoperfusion Sales Share by Country (2021-2032) Figure 53. China Hemoperfusion Revenue Share by Type (2021-2032) Figure 54. China Hemoperfusion Sales Share by Type (2021-2032) Figure 55. China Hemoperfusion Revenue Share by Application (2021-2032) Figure 56. China Hemoperfusion Sales Share by Application (2021-2032) Figure 57. Asia Hemoperfusion Revenue Share by Type (2021-2032) Figure 58. Asia Hemoperfusion Sales Share by Type (2021-2032) Figure 59. Asia Hemoperfusion Revenue Share by Application (2021-2032) Figure 60. Asia Hemoperfusion Sales Share by Application (2021-2032) Figure 61. Asia Hemoperfusion Revenue Share by Country (2021-2032) Figure 62. Asia Hemoperfusion Sales Share by Country (2021-2032) Figure 63. SAMEA Hemoperfusion Revenue Share by Type (2021-2032) Figure 64. SAMEA Hemoperfusion Sales Share by Type (2021-2032) Figure 65. SAMEA Hemoperfusion Revenue Share by Application (2021-2032) Figure 66. SAMEA Hemoperfusion Sales Share by Application (2021-2032) Figure 67. SAMEA Hemoperfusion Revenue Share by Country (2021-2032) Figure 68. SAMEA Hemoperfusion Sales Share by Country (2021-2032) Figure 69. Hemoperfusion Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Hemoperfusion Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Activated Carbon Adsorption
  • Resin Adsorption
Applications
  • Hepatic Encephalopathy
  • Certain Autoimmune Diseases
  • Drug Overdose
  • Specific Intoxications
  • Others
Companies covered
  • Jafron Biomedical
  • Baxter (Gambro)
  • Asahi-Kasei
  • Biosun Medical
  • Kaneka
  • Toray Medical
  • Cytosorbents
  • Aier
  • Zibo Kangbei

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hemoperfusion Market by Type
  3. 1.2.1 Global Hemoperfusion Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Activated Carbon Adsorption
  5. 1.2.3 Resin Adsorption
  6. 1.3 Hemoperfusion Market by Application
  7. 1.3.1 Global Hemoperfusion Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hepatic Encephalopathy
  9. 1.3.3 Certain Autoimmune Diseases
  10. 1.3.4 Drug Overdose
  11. 1.3.5 Specific Intoxications
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Hemoperfusion Market Dynamics
  1. 2.1 Hemoperfusion Industry Trends
  2. 2.2 Hemoperfusion Industry Drivers
  3. 2.3 Hemoperfusion Industry Opportunities and Challenges
  4. 2.4 Hemoperfusion Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hemoperfusion Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hemoperfusion Revenue by Region
  3. 3.2.1 Global Hemoperfusion Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hemoperfusion Revenue by Region (2021-2026)
  5. 3.2.3 Global Hemoperfusion Revenue by Region (2027-2032)
  6. 3.2.4 Global Hemoperfusion Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hemoperfusion Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hemoperfusion Sales by Region
  9. 3.4.1 Global Hemoperfusion Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hemoperfusion Sales by Region (2021-2026)
  11. 3.4.3 Global Hemoperfusion Sales by Region (2027-2032)
  12. 3.4.4 Global Hemoperfusion Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hemoperfusion Revenue by Manufacturers
  2. 4.1.1 Global Hemoperfusion Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hemoperfusion Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hemoperfusion Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hemoperfusion Sales by Manufacturers
  6. 4.2.1 Global Hemoperfusion Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hemoperfusion Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hemoperfusion Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hemoperfusion Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hemoperfusion Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hemoperfusion Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hemoperfusion Manufacturers, Product Type & Application
  13. 4.7 Global Hemoperfusion Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hemoperfusion Market CR5 and HHI
  16. 4.8.2 2025 Hemoperfusion Tier 1, Tier 2, and Tier 3
5 Hemoperfusion Market by Type
  1. 5.1 Global Hemoperfusion Revenue by Type
  2. 5.1.1 Global Hemoperfusion Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hemoperfusion Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hemoperfusion Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hemoperfusion Sales by Type
  6. 5.2.1 Global Hemoperfusion Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hemoperfusion Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Hemoperfusion Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hemoperfusion Price by Type
6 Hemoperfusion Market by Application
  1. 6.1 Global Hemoperfusion Revenue by Application
  2. 6.1.1 Global Hemoperfusion Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hemoperfusion Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hemoperfusion Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hemoperfusion Sales by Application
  6. 6.2.1 Global Hemoperfusion Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hemoperfusion Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Hemoperfusion Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hemoperfusion Price by Application
7 Company Profiles
  1. 7.1 Jafron Biomedical
  2. 7.1.1 Jafron Biomedical Company Information
  3. 7.1.2 Jafron Biomedical Business Overview
  4. 7.1.3 Jafron Biomedical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Jafron Biomedical Hemoperfusion Product Portfolio
  6. 7.1.5 Jafron Biomedical Recent Developments
  7. 7.2 Baxter (Gambro)
  8. 7.2.1 Baxter (Gambro) Company Information
  9. 7.2.2 Baxter (Gambro) Business Overview
  10. 7.2.3 Baxter (Gambro) Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Baxter (Gambro) Hemoperfusion Product Portfolio
  12. 7.2.5 Baxter (Gambro) Recent Developments
  13. 7.3 Asahi-Kasei
  14. 7.3.1 Asahi-Kasei Company Information
  15. 7.3.2 Asahi-Kasei Business Overview
  16. 7.3.3 Asahi-Kasei Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Asahi-Kasei Hemoperfusion Product Portfolio
  18. 7.3.5 Asahi-Kasei Recent Developments
  19. 7.4 Biosun Medical
  20. 7.4.1 Biosun Medical Company Information
  21. 7.4.2 Biosun Medical Business Overview
  22. 7.4.3 Biosun Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Biosun Medical Hemoperfusion Product Portfolio
  24. 7.4.5 Biosun Medical Recent Developments
  25. 7.5 Kaneka
  26. 7.5.1 Kaneka Company Information
  27. 7.5.2 Kaneka Business Overview
  28. 7.5.3 Kaneka Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Kaneka Hemoperfusion Product Portfolio
  30. 7.5.5 Kaneka Recent Developments
  31. 7.6 Toray Medical
  32. 7.6.1 Toray Medical Company Information
  33. 7.6.2 Toray Medical Business Overview
  34. 7.6.3 Toray Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Toray Medical Hemoperfusion Product Portfolio
  36. 7.6.5 Toray Medical Recent Developments
  37. 7.7 Cytosorbents
  38. 7.7.1 Cytosorbents Company Information
  39. 7.7.2 Cytosorbents Business Overview
  40. 7.7.3 Cytosorbents Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Cytosorbents Hemoperfusion Product Portfolio
  42. 7.7.5 Cytosorbents Recent Developments
  43. 7.8 Aier
  44. 7.8.1 Aier Company Information
  45. 7.8.2 Aier Business Overview
  46. 7.8.3 Aier Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Aier Hemoperfusion Product Portfolio
  48. 7.8.5 Aier Recent Developments
  49. 7.9 Zibo Kangbei
  50. 7.9.1 Zibo Kangbei Company Information
  51. 7.9.2 Zibo Kangbei Business Overview
  52. 7.9.3 Zibo Kangbei Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Zibo Kangbei Hemoperfusion Product Portfolio
  54. 7.9.5 Zibo Kangbei Recent Developments
8 North America
  1. 8.1 North America Hemoperfusion Market Size by Type
  2. 8.1.1 North America Hemoperfusion Revenue by Type (2021-2032)
  3. 8.1.2 North America Hemoperfusion Sales by Type (2021-2032)
  4. 8.1.3 North America Hemoperfusion Price by Type (2021-2032)
  5. 8.2 North America Hemoperfusion Market Size by Application
  6. 8.2.1 North America Hemoperfusion Revenue by Application (2021-2032)
  7. 8.2.2 North America Hemoperfusion Sales by Application (2021-2032)
  8. 8.2.3 North America Hemoperfusion Price by Application (2021-2032)
  9. 8.3 North America Hemoperfusion Market Size by Country
  10. 8.3.1 North America Hemoperfusion Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hemoperfusion Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hemoperfusion Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Hemoperfusion Market Size by Type
  2. 9.1.1 Europe Hemoperfusion Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hemoperfusion Sales by Type (2021-2032)
  4. 9.1.3 Europe Hemoperfusion Price by Type (2021-2032)
  5. 9.2 Europe Hemoperfusion Market Size by Application
  6. 9.2.1 Europe Hemoperfusion Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hemoperfusion Sales by Application (2021-2032)
  8. 9.2.3 Europe Hemoperfusion Price by Application (2021-2032)
  9. 9.3 Europe Hemoperfusion Market Size by Country
  10. 9.3.1 Europe Hemoperfusion Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hemoperfusion Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hemoperfusion Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Hemoperfusion Market Size by Type
  2. 10.1.1 China Hemoperfusion Revenue by Type (2021-2032)
  3. 10.1.2 China Hemoperfusion Sales by Type (2021-2032)
  4. 10.1.3 China Hemoperfusion Price by Type (2021-2032)
  5. 10.2 China Hemoperfusion Market Size by Application
  6. 10.2.1 China Hemoperfusion Revenue by Application (2021-2032)
  7. 10.2.2 China Hemoperfusion Sales by Application (2021-2032)
  8. 10.2.3 China Hemoperfusion Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hemoperfusion Market Size by Type
  2. 11.1.1 Asia Hemoperfusion Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hemoperfusion Sales by Type (2021-2032)
  4. 11.1.3 Asia Hemoperfusion Price by Type (2021-2032)
  5. 11.2 Asia Hemoperfusion Market Size by Application
  6. 11.2.1 Asia Hemoperfusion Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hemoperfusion Sales by Application (2021-2032)
  8. 11.2.3 Asia Hemoperfusion Price by Application (2021-2032)
  9. 11.3 Asia Hemoperfusion Market Size by Country
  10. 11.3.1 Asia Hemoperfusion Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hemoperfusion Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hemoperfusion Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hemoperfusion Market Size by Type
  2. 12.1.1 SAMEA Hemoperfusion Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hemoperfusion Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hemoperfusion Price by Type (2021-2032)
  5. 12.2 SAMEA Hemoperfusion Market Size by Application
  6. 12.2.1 SAMEA Hemoperfusion Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hemoperfusion Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hemoperfusion Price by Application (2021-2032)
  9. 12.3 SAMEA Hemoperfusion Market Size by Country
  10. 12.3.1 SAMEA Hemoperfusion Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hemoperfusion Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hemoperfusion Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hemoperfusion Value Chain Analysis
  2. 13.1.1 Hemoperfusion Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hemoperfusion Production Mode & Process
  6. 13.2 Hemoperfusion Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hemoperfusion Distributors
  9. 13.2.3 Hemoperfusion Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst